list of investigational hallucinogens and entactogens list of investigational hallucinogens and entactogens this is a list of investigational hallucinogens and entactogens, or hallucinogens and entactogens that are currently under formal development for clinical use but are not yet approved. many of the indications are not for continuous medication therapy but rather for medication-assisted psychotherapy or short-term use only. chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. hallucinogens psychedelics dimethyltryptamine (dmt) – addiction, substance-related disorders – entheon biomedical lysergic acid diethylamide (lsd; "lucy") – anxiety disorders, attention-deficit hyperactivity disorder – maps, mindmed psilocybin (comp-360, pb-1818, psy-0.1–0.6, myco-001) – bipolar depression, depressive disorders, major depressive disorder, somatoform disorders – compass pathways, psybio therapeutics, mydecine dissociatives arketamine ((r)-ketamine; hr-071603) – depressive disorders – jiangsu hengrui medicine esketamine ((s)-ketamine; pg061) – bipolar depression, depressive disorders – celon pharma ketamine (ele-ket+, r-107, shx-001, pmi-100, pmi-150, sls-002, tur-002; ereska) – major depressive disorder, suicidal ideation, cluster headaches – eleusis, douglas pharmaceuticals, shenox pharmaceuticals, cch pharmaceuticals, seelos therapeutics others/mixed 18-methoxycoronaridine (18-mc) – leishmaniasis, opioid-related disorders, substance-related disorders – mindmed ibogaine – opioid-related disorders – atai life sciences/demerx entactogens midomafetamine (mdma; "ecstasy") – post-traumatic stress disorders, mood disorders, substance-related disorders, social anxiety in autism – maps, mindmed myco-002 – mdma-like entactogen – mydecine others/unsorted ketanserin – lsd neutralization – mindmed mixed lysergic acid diethylamide/midomafetamine (lsd/mdma) – psychedelic-assisted psychotherapy – mindmed